Parkinson’s Patients May Benefit From Ketamine, PharmaTher Appeals…
Specialized pharmaceutical company PharmaTher stocks PHRRF has submitted a fast track application to the Food and Drug Administration (FDA) for KETARXa ketamine drug that may
Home » PharmaTher
Specialized pharmaceutical company PharmaTher stocks PHRRF has submitted a fast track application to the Food and Drug Administration (FDA) for KETARXa ketamine drug that may
Ketamine Specialty Company PharmaTher Holdings Ltd. PHRRF submitted Type B Package of meetings to the FDA to discuss the remaining requirements for the KETARX on-body
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents